The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, ...

The scientists significantly reduced nasal inflammation and improved the sense of smell in mice by using a vitamin D nasal ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper device was effective in treating acute ...

I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...

Quick administration of naloxone – also known as Narcan – by a first responder, loved one or bystander can revive an opioid user who has overdosed. If administered in time, naloxone is effective in ...

Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.